Valean

Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is a global diversified pharmaceutical and medical device company headquartered in Laval, Quebec. The company develops, manufactures, and markets a wide range of products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Following a significant corporate restructuring and rebranding in 2018, the company has focused on its core business units, including Bausch + Lomb, Salix Pharmaceuticals, and Ortho Dermatologics. Its extensive portfolio includes market-leading brands such as Xifaxan, Lumify, and Duobrii, alongside a major presence in the contact lens and ophthalmic surgical markets.